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Background:  T1 mapping allows for accurate assessment of diffuse myocardial fibrosis. The relationship between diffuse fibrosis based 
on T1 mapping and ventricular tachycardia (VT) is unknown.
methods:  Patients were referred for CMR evaluation of new-onset cardiomyopathy (CMP). 10 patients with a history of VT and 11 EF-
matched controls with non-ischemic CMP were enrolled. No patients had a history of hypertrophic or restrictive CMP. Patients with VT had 
documented sustained monomorphic VT (including idiopathic VT), polymorphic VT, or ventricular fibrillation. Using 1.5T MR scanner, non-
contrast T1 mapping images of LV were acquired by using slice-interleaved T1 (STONE) sequence.
results:  On LGE MRI, 3 VT patients and 1 control subject had myocardial enhancement. On segment-based analysis, after excluding 8 
segments with positive LGE, T1 value was significantly higher in VT patients (153 segments) compared to control subjects (175 segments) 
(1137 ±87 vs. 1110 ±57 ms; P<0.001)(Figure). There was no significant difference between the two groups in terms of LVEF (47 vs. 51%; 
p=0.62), LV end-diastolic volume index (106 vs. 100mL/m2; p=0.76), or LV mass index (54 vs. 58g/m2; p=0.76). 
conclusion:  Patients with a history of VT had significantly higher T1 value when compared to EF-matched control s despite similar LV 
anatomy. T1 mapping might provide an accurate and non-invasive assessment of subclinical myocardial dysfunction in patients with non-
ischemic cardiomyopathy with potential substrate for VT.
 
